Glycan Shifting on Hepatitis C Virus (HCV) E2 Glycoprotein Is a Mechanism for Escape from Broadly Neutralizing Antibodies-Reference-Cited by-同舟云学术

Glycan Shifting on Hepatitis C Virus (HCV) E2 Glycoprotein Is a Mechanism for Escape from Broadly Neutralizing Antibodies

Published:2013-06 Issue:11 Volume:425 Page:1899-1914
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Pantua Homer,Diao Jingyu,Ultsch Mark,Hazen Meredith,Mathieu Mary,McCutcheon Krista,Takeda Kentaro,Date Shailesh,Cheung Tommy K.,Phung Qui,Hass Phil,Arnott David,Hongo Jo-Anne,Matthews David J.,Brown Alex,Patel Arvind H.,Kelley Robert F.,Eigenbrot Charles,Kapadia Sharookh B.

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference63 articles.

1. Studies of non-A, non-B hepatitis and characterization of the hepatitis C virus in chimpanzees;Bradley;Curr. Top. Microbiol. Immunol.,2000

2. Identification of novel sequences at the 5′ terminus of the hepatitis C virus genome;Trowbridge;J. Viral Hepat.,1998

3. Secondary structure determination of the conserved 98-base sequence at the 3′ terminus of hepatitis C virus genome RNA;Blight;J. Virol.,1997

4. Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice;McCaffrey;Mol. Ther.,2002

5. Internal ribosome entry site within hepatitis C virus RNA;Tsukiyama-Kohara;J. Virol.,1992

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies;Viruses;2023-05-11

2. Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412–425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles;Microbiology Spectrum;2023-04-13

3. Identification of novel neutralizing determinants for protection against HCV;Hepatology;2023-02-17

4. Insights into Hepatitis C Virus E2_core Interactions with Human Cellular Receptor CD81 at Different pHs from Molecular Simulations;The Journal of Physical Chemistry B;2022-10-18

5. Patient-derived monoclonal antibody neutralizes HCV infection in vitro and vivo without generating escape mutants;PLOS ONE;2022-09-22